{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:29:18Z","timestamp":1791304158877,"version":"4.3.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02884-7","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T11:25:28Z","timestamp":1754911528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells"],"prefix":"10.1186","volume":"22","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"2884_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-7091-9300-6_8","volume":"7","author":"H FELDMANN","year":"1993","unstructured":"FELDMANN H, KLENK H D SANCHEZA. Molecular biology and evolution of filoviruses [J]. Archives Virol Suppl. 1993;7:81\u2013100.","journal-title":"Archives Virol Suppl"},{"key":"2884_CR2","doi-asserted-by":"crossref","unstructured":"FELDMANN H, KLENK HD. Marburg and Ebola viruses [J]. Advances in virus research, 1996, 47: 1\u201352.","DOI":"10.1016\/S0065-3527(08)60733-2"},{"issue":"4","key":"2884_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/19420862.2017.1299848","volume":"9","author":"JW FROUDE","year":"2017","unstructured":"FROUDE JW, PELAT T, MIETHE S, et al. Generation and characterization of protective antibodies to Marburg virus [J]. mAbs. 2017;9(4):696\u2013703.","journal-title":"mAbs"},{"issue":"1","key":"2884_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/21505594.2022.2054760","volume":"13","author":"T ABIR M H, RAHMAN","year":"2022","unstructured":"ABIR M H, RAHMAN T, DAS A, et al. Pathogenicity and virulence of Marburg virus [J]. Virulence. 2022;13(1):609\u201333.","journal-title":"Virulence"},{"key":"2884_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","volume":"159","author":"MS MEHAND","year":"2018","unstructured":"MEHAND MS, AL-SHORBAJI F, MILLETT P, et al. The WHO R&D blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts [J]. Antiviral Res. 2018;159:63\u20137.","journal-title":"Antiviral Res"},{"key":"2884_CR6","first-page":"233","volume":"99","author":"K KORTEPETER M G, DIERBERG","year":"2020","unstructured":"KORTEPETER M G, DIERBERG K. Marburg virus disease: A summary for clinicians [J]. Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis. 2020;99:233\u201342.","journal-title":"Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis"},{"key":"2884_CR7","doi-asserted-by":"crossref","unstructured":"ZHANG Y, ZHANG M, WU H et al. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus [J]. eLife, 2024, 12.","DOI":"10.7554\/eLife.91181.3"},{"issue":"1\u20132","key":"2884_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000149300","volume":"18","author":"KILEY M P","year":"1982","unstructured":"KILEY M P, BOWEN E T, EDDY G A, et al. Filoviridae: a taxonomic home for Marburg and Ebola viruses? [J]. Intervirology. 1982;18(1\u20132):24\u201332.","journal-title":"Intervirology"},{"issue":"10","key":"2884_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","volume":"3","author":"T GOLDSTEIN","year":"2018","unstructured":"GOLDSTEIN T, ANTHONY S J GBAKIMAA, et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses [J]. Nat Microbiol. 2018;3(10):1084\u20139.","journal-title":"Nat Microbiol"},{"key":"2884_CR10","doi-asserted-by":"crossref","unstructured":"ILINYKH PA, HUANG K, SANTOS R I, et al. Non-neutralizing antibodies from a Marburg infection survivor mediate protection by Fc-Effector functions and by enhancing efficacy of other antibodies [J]. Volume 27. Cell host & microbe; 2020. 6976\u2013\u200991.e11.","DOI":"10.1016\/j.chom.2020.03.025"},{"issue":"5","key":"2884_CR11","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1128\/JVI.03118-12","volume":"87","author":"CARROLL S A","year":"2013","unstructured":"CARROLL S A, TOWNER J S, SEALY T K, et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences [J]. J Virol. 2013;87(5):2608\u201316.","journal-title":"J Virol"},{"issue":"1","key":"2884_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0168-1702(92)90027-7","volume":"24","author":"H FELDMANN","year":"1992","unstructured":"FELDMANN H, M\u00fcHLBERGER E, RANDOLF A, et al. Marburg virus, a filovirus: messenger rnas, gene order, and regulatory elements of the replication cycle [J]. Virus Res. 1992;24(1):1\u201319.","journal-title":"Virus Res"},{"issue":"22","key":"2884_CR13","doi-asserted-by":"publisher","first-page":"12277","DOI":"10.1128\/JVI.78.22.12277-12287.2004","volume":"78","author":"L KOLESNIKOVA","year":"2004","unstructured":"KOLESNIKOVA L, BERGH\u00f6FER B, BAMBERG S, et al. Multivesicular bodies as a platform for formation of the Marburg virus envelope [J]. J Virol. 2004;78(22):12277\u201387.","journal-title":"J Virol"},{"issue":"4","key":"2884_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1586\/14760584.2014.885841","volume":"13","author":"A MARZI","year":"2014","unstructured":"MARZI A, FELDMANN H. Ebola virus vaccines: an overview of current approaches [J]. Expert Rev Vaccines. 2014;13(4):521\u201331.","journal-title":"Expert Rev Vaccines"},{"issue":"10373","key":"2884_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(22)02400-X","volume":"401","author":"MJ HAMER","year":"2023","unstructured":"HAMER MJ, HOUSER K V, HOFSTETTER A R, et al. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial [J]. Lancet (London England). 2023;401(10373):294\u2013302.","journal-title":"Lancet (London England)"},{"issue":"1","key":"2884_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0042-6822(91)90680-A","volume":"182","author":"H FELDMANN","year":"1991","unstructured":"FELDMANN H, WILL C, SCHIKORE M, et al. Glycosylation and oligomerization of the Spike protein of Marburg virus [J]. Virology. 1991;182(1):353\u20136.","journal-title":"Virology"},{"issue":"1","key":"2884_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1999.0110","volume":"268","author":"U VOLCHKOV V E, VOLCHKOVA V A, STR\u00f6HE","year":"2000","unstructured":"VOLCHKOV V E, VOLCHKOVA V A, STR\u00f6HER U, et al. Proteolytic processing of Marburg virus glycoprotein [J]. Virology. 2000;268(1):1\u20136.","journal-title":"Virology"},{"issue":"6","key":"2884_CR18","doi-asserted-by":"publisher","first-page":"e1005016","DOI":"10.1371\/journal.ppat.1005016","volume":"11","author":"ML FUSCO","year":"2015","unstructured":"FUSCO ML, HASHIGUCHI T, CASSAN R, et al. Protective mAbs and Cross-Reactive mAbs Raised by immunization with engineered Marburg virus gps [J]. PLoS Pathog. 2015;11(6):e1005016.","journal-title":"PLoS Pathog"},{"key":"2884_CR19","doi-asserted-by":"crossref","unstructured":"LI T, ZHENG Q, YU H, et al. SARS-CoV-2 Spike produced in insect cells elicits high neutralization titres in non-human primates [J]. Volume 9. Emerging microbes & infections; 2020. pp. 2076\u201390. 1.","DOI":"10.1080\/22221751.2020.1821583"},{"issue":"1","key":"2884_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/imr.12005","volume":"250","author":"JP JULIEN","year":"2012","unstructured":"JULIEN JP, LEE P S, WILSON I A. Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA [J]. Immunol Rev. 2012;250(1):180\u201398.","journal-title":"Immunol Rev"},{"issue":"19","key":"2884_CR21","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.1128\/JVI.00959-06","volume":"80","author":"GEISBERTJB DADDARIO-DICAPRIO K M, GEISBERT T W","year":"2006","unstructured":"DADDARIO-DICAPRIO K M, GEISBERT T W GEISBERTJB, et al. Cross-protection against Marburg virus strains by using a live, attenuated Recombinant vaccine [J]. J Virol. 2006;80(19):9659\u201366.","journal-title":"J Virol"},{"key":"2884_CR22","doi-asserted-by":"crossref","unstructured":"KING L B, FUSCO M L, FLYAK A I, et al. The Marburgvirus-Neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding [J]. Volume 23. Cell host & microbe; 2018. pp. 101\u2013e94. 1.","DOI":"10.1016\/j.chom.2017.12.003"},{"issue":"5","key":"2884_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2015.01.031","volume":"160","author":"D FLYAK A I, ILINYKH P A, MURIN C","year":"2015","unstructured":"FLYAK A I, ILINYKH P A, MURIN C D, et al. Mechanism of human antibody-mediated neutralization of Marburg virus [J]. Cell. 2015;160(5):893\u2013903.","journal-title":"Cell"},{"issue":"1","key":"2884_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jmb.2010.08.033","volume":"403","author":"KONGL SHEPPARD N C","year":"2010","unstructured":"SHEPPARD N C KONGL, STEWART-JONES G B E, et al. Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity [J]. J Mol Biol. 2010;403(1):131\u201347.","journal-title":"J Mol Biol"},{"key":"2884_CR25","doi-asserted-by":"crossref","unstructured":"URBANOWICZ RA, WANG R, SCHIEL JE et al. Antigenicity and immunogenicity of differentially glycosylated hepatitis C virus E2 envelope proteins expressed in mammalian and insect cells [J]. J Virol, 2019, 93(7).","DOI":"10.1128\/JVI.01403-18"},{"issue":"4","key":"2884_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/glycob\/2.4.299","volume":"2","author":"H GEYER","year":"1992","unstructured":"GEYER H, WILL C, FELDMANN H, et al. Carbohydrate structure of Marburg virus glycoprotein [J]. Glycobiology. 1992;2(4):299\u2013312.","journal-title":"Glycobiology"},{"issue":"1","key":"2884_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/viro.1996.0582","volume":"225","author":"S BECKER","year":"1996","unstructured":"BECKER S, KLENK H D, M\u00fcHLBERGER E. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells [J]. Virology. 1996;225(1):145\u201355.","journal-title":"Virology"},{"issue":"1\u20132","key":"2884_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0014-5793(93)81476-G","volume":"323","author":"A BUKREYEV","year":"1993","unstructured":"BUKREYEV A, VOLCHKOV V E, BLINOV V M, et al. The GP-protein of Marburg virus contains the region similar to the \u2018immunosuppressive domain\u2019 of oncogenic retrovirus P15E proteins [J]. FEBS Lett. 1993;323(1\u20132):183\u20137.","journal-title":"FEBS Lett"},{"issue":"23","key":"2884_CR29","doi-asserted-by":"publisher","first-page":"10486","DOI":"10.1128\/JVI.01462-16","volume":"90","author":"D LI","year":"2016","unstructured":"LI D, VON SCHAEWEN M, WANG X, et al. Altered glycosylation patterns increase immunogenicity of a subunit hepatitis C virus vaccine, inducing neutralizing antibodies which confer protection in mice [J]. J Virol. 2016;90(23):10486\u201398.","journal-title":"J Virol"},{"issue":"47","key":"2884_CR30","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1016\/j.vaccine.2022.09.057","volume":"40","author":"T DENG","year":"2022","unstructured":"DENG T, LI T, CHEN G, et al. Characterization and immunogenicity of SARS-CoV-2 Spike proteins with varied glycosylation [J]. Vaccine. 2022;40(47):6839\u201348.","journal-title":"Vaccine"},{"issue":"10","key":"2884_CR31","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1128\/jvi.74.10.4933-4937.2000","volume":"74","author":"MC CHAN S Y, SPECK R F, MA","year":"2000","unstructured":"CHAN S Y, SPECK R F, MA MC, et al. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses [J]. J Virol. 2000;74(10):4933\u20137.","journal-title":"J Virol"},{"key":"2884_CR32","doi-asserted-by":"publisher","first-page":"586595","DOI":"10.3389\/fimmu.2020.586595","volume":"11","author":"V AGNOLON","year":"2020","unstructured":"AGNOLON V, KISELJAK D WURMMJ, et al. Designs and characterization of subunit Ebola GP vaccine candidates: implications for immunogenicity [J]. Front Immunol. 2020;11:586595.","journal-title":"Front Immunol"},{"issue":"21","key":"2884_CR33","doi-asserted-by":"publisher","first-page":"11735","DOI":"10.1128\/JVI.01084-12","volume":"86","author":"DE VRIES R P","year":"2012","unstructured":"DE VRIES R P, SMIT C H, DE BRUIN E, et al. Glycan-dependent immunogenicity of Recombinant soluble trimeric hemagglutinin [J]. J Virol. 2012;86(21):11735\u201344.","journal-title":"J Virol"},{"issue":"10","key":"2884_CR34","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/v3101909","volume":"3","author":"F HELLE","year":"2011","unstructured":"HELLE F, DUVERLIE G. The hepatitis C virus glycan shield and evasion of the humoral immune response [J]. Viruses. 2011;3(10):1909\u201332.","journal-title":"Viruses"},{"issue":"1","key":"2884_CR35","doi-asserted-by":"publisher","first-page":"8133","DOI":"10.1038\/s41467-024-51021-5","volume":"15","author":"S KHURANA","year":"2024","unstructured":"KHURANA S, GRUBBS G, RAVICHANDRAN S, et al. Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design [J]. Nat Commun. 2024;15(1):8133.","journal-title":"Nat Commun"},{"key":"2884_CR36","doi-asserted-by":"crossref","unstructured":"PALOMARES L A, SRIVASTAVA I K, RAM\u00edREZ OT et al. Glycobiotechnology of the insect Cell-Baculovirus expression system technology [J]. Advances in biochemical engineering\/biotechnology, 2021, 175: 71\u201392.","DOI":"10.1007\/10_2018_61"},{"issue":"2","key":"2884_CR37","first-page":"151","volume":"382","author":"R MARCHAL I, JARVIS D L, CACAN","year":"2001","unstructured":"MARCHAL I, JARVIS D L, CACAN R, et al. Glycoproteins from insect cells: sialylated or not? [J]. Biol Chem. 2001;382(2):151\u20139.","journal-title":"Biol Chem"},{"issue":"12","key":"2884_CR38","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00018-005-5589-y","volume":"63","author":"F LEHMANN","year":"2006","unstructured":"LEHMANN F, TIRALONGO E. Sialic acid-specific lectins: occurrence, specificity and function [J]. Cell Mol Life Sci. 2006;63(12):1331\u201354.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2884_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.sbi.2009.06.003","volume":"19","author":"SCHAUER R","year":"2009","unstructured":"SCHAUER R. Sialic acids as regulators of molecular and cellular interactions [J]. Curr Opin Struct Biol. 2009;19(5):507\u201314.","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"2884_CR40","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1038\/s41598-017-15416-3","volume":"7","author":"C CLARKE E C, COLLAR A L, YE","year":"2017","unstructured":"CLARKE E C, COLLAR A L, YE C, et al. Production and purification of filovirus glycoproteins in insect and mammalian cell lines [J]. Sci Rep. 2017;7(1):15091.","journal-title":"Sci Rep"},{"issue":"18","key":"2884_CR41","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1128\/JVI.00784-09","volume":"83","author":"M REYNARD O, BOROWIAK","year":"2009","unstructured":"REYNARD O, BOROWIAK M. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins [J]. J Virol. 2009;83(18):9596\u2013601.","journal-title":"J Virol"},{"issue":"9","key":"2884_CR42","doi-asserted-by":"publisher","first-page":"e1001098","DOI":"10.1371\/journal.ppat.1001098","volume":"6","author":"JR FRANCICA","year":"2010","unstructured":"FRANCICA JR, VARELA-ROHENA A, MEDVEC A, et al. Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein [J]. PLoS Pathog. 2010;6(9):e1001098.","journal-title":"PLoS Pathog"},{"issue":"5","key":"2884_CR43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","volume":"160","author":"T HASHIGUCHI","year":"2015","unstructured":"HASHIGUCHI T, FUSCO M L, BORNHOLDT Z A, et al. Structural basis for Marburg virus neutralization by a cross-reactive human antibody [J]. Cell. 2015;160(5):904\u201312.","journal-title":"Cell"},{"issue":"13","key":"2884_CR44","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","volume":"79","author":"A GOFFARD","year":"2005","unstructured":"GOFFARD A, CALLENS N. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins [J]. J Virol. 2005;79(13):8400\u20139.","journal-title":"J Virol"},{"issue":"15","key":"2884_CR45","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1128\/JVI.00127-07","volume":"81","author":"F HELLE","year":"2007","unstructured":"HELLE F, GOFFARD A, MOREL V, et al. The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein [J]. J Virol. 2007;81(15):8101\u201311.","journal-title":"J Virol"},{"issue":"1","key":"2884_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12896-024-00885-y","volume":"24","author":"MAKOAH N A","year":"2024","unstructured":"MAKOAH N A, LITABE M M, SIMO F B N, et al. Purification and characterization of soluble Recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells [J]. BMC Biotechnol. 2024;24(1):59.","journal-title":"BMC Biotechnol"},{"issue":"7","key":"2884_CR47","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1073\/pnas.1323954111","volume":"111","author":"JR CHEN","year":"2014","unstructured":"CHEN JR, YU Y H, TSENG Y C, et al. Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections [J]. Proc Natl Acad Sci USA. 2014;111(7):2476\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2884_CR48","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1073\/pnas.1819197116","volume":"116","author":"TSENG Y C","year":"2019","unstructured":"TSENG Y C, WU C Y, LIU M L, et al. Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections [J]. Proc Natl Acad Sci USA. 2019;116(10):4200\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2884_CR49","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.celrep.2017.04.013","volume":"19","author":"T ZHOU","year":"2017","unstructured":"ZHOU T, DORIA-ROSE N A, CHENG C, et al. Quantification of the impact of the HIV-1-Glycan shield on antibody elicitation [J]. Cell Rep. 2017;19(4):719\u201332.","journal-title":"Cell Rep"},{"key":"2884_CR50","doi-asserted-by":"crossref","unstructured":"EBEL H, BENECKE T. VOLLMER B. Stabilisation of viral membrane fusion proteins in prefusion conformation by structure-Based design for structure determination and vaccine development [J]. Viruses, 2022, 14(8).","DOI":"10.3390\/v14081816"},{"issue":"11","key":"2884_CR51","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41579-023-00919-w","volume":"21","author":"LANGEDIJK A C","year":"2023","unstructured":"LANGEDIJK A C. BONT L J. Respiratory syncytial virus infection and novel interventions [J]. Nat Rev Microbiol. 2023;21(11):734\u201349.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2884_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41467-020-20321-x","volume":"12","author":"J JURASZEK","year":"2021","unstructured":"JURASZEK J, RUTTEN L, BLOKLAND S, et al. Stabilizing the closed SARS-CoV-2 Spike trimer [J]. Nat Commun. 2021;12(1):244.","journal-title":"Nat Commun"},{"key":"2884_CR53","doi-asserted-by":"crossref","unstructured":"AMANAT F, STROHMEIER S, RATHNASINGHE R et al. Introduction of two prolines and removal of the polybasic cleavage site lead to higher efficacy of a Recombinant Spike-Based SARS-CoV-2 vaccine in the mouse model [J]. mBio, 2021, 12(2).","DOI":"10.1128\/mBio.02648-20"},{"issue":"13","key":"2884_CR54","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1016\/j.celrep.2020.03.025","volume":"30","author":"S RUTTEN L, GILMAN M S A, BLOKLAND","year":"2020","unstructured":"RUTTEN L, GILMAN M S A, BLOKLAND S, et al. Structure-Based design of Prefusion-Stabilized filovirus glycoprotein trimers [J]. Cell Rep. 2020;30(13):4540\u2013e503.","journal-title":"Cell Rep"}],"updated-by":[{"DOI":"10.1186\/s12985-025-02951-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000}}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02884-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02884-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02884-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:02:59Z","timestamp":1759136579000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02884-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02884-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The author name Guanying Zhang is missed to denote as a co-corresponding author and it has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12985-025-02951-z","URL":"https:\/\/doi.org\/10.1186\/s12985-025-02951-z","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BALB\/c mice studies were approved by the Institutional Animal Care and Use Committee of the Laboratory Animal Centre of the Sino Animal (Beijing) Science and Technology Development Company (approval no. IACUC-20240301YZA-3R) in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript has been given publication permission by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}